Walleye Capital
ASLN

Walleye Capital’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Walleye Capital’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,304
Closed -$11.3K – 6132
2024
Q1 		$11.3K Buy
+2,304
New +$11.5K ﹤0.01% 5048

Other funds holding ASLN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Walleye Capital's ASLN Position: Q2 2024 in Review

Walleye Capital sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q2 2024, closing a stake of 2,304 shares — an estimated $11.3K sold.

Walleye Capital first reported a position in ASLN in Q1 2024 and held it in 1 quarter. The position peaked at $11.3K in Q1 2024. 19 funds tracked by Wall St. Rank hold ASLN as of Q2 2024.

  • Walleye Capital reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q2 2024 after selling out during the quarter.
  • Walleye Capital sold 2,304 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q2 2024, an estimated $11.3K.
  • Walleye Capital first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2024 and held it in 1 quarter.
  • Walleye Capital's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $11.3K in Q1 2024.
  • 19 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q2 2024.

Based on Walleye Capital's 13F filing for Q2 2024, filed 14 Aug 2024.